Positive and negative selection of natural autoreactive B cells

Advances in Experimental Medicine and Biology

Volumn 750, Issue , 2012, Pages 227-238

  Hardy, Richard R ^a   Hayakawa, Kyoko ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; THY 1 ANTIGEN; THYMOCYTE ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; IMMUNOGLOBULIN MU CHAIN; LYMPHOCYTE ANTIBODY; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CELL FATE; CELL MATURATION; CELL SELECTION; CELLULAR DISTRIBUTION; CROSS LINKING; ENGRAFTMENT; HUMAN; INTRACELLULAR SIGNALING; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; THYMOCYTE; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; IMMUNOLOGY; MOUSE; SPLEEN; TRANSGENIC MOUSE;

ANIMALS; ANTIBODY SPECIFICITY; ANTILYMPHOCYTE SERUM; AUTOANTIBODIES; AUTOANTIGENS; B-LYMPHOCYTES; CELL DIFFERENTIATION; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN MU-CHAINS; MICE; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, B-CELL; SPLEEN; THYMOCYTES;

EID: 84866784928     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3461-0_17     Document Type: Article

References (28)

1. Hayakawa K, Hardy RR, Parks DR et al. The "Ly-1 B" cell subpopulation in normal, immunodefective, and autoimmune mice. J Exp Med 1983; 157:202-18; PMID:6600267; http://dx.doi.org/10.1084/jem.157.1.202. (Pubitemid 13176184)
2. Hayakawa K, Hardy RR, Honda M et al. Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci USA 1984; 81:2494-8; PMID:6609363; http://dx.doi.org/10.1073/ pnas.81.8.2494.
3. Sidman CL, Shultz LD, Hardy RR et al. Production of immunoglobulin isotypes by Ly-1+ B cells in viable motheaten and normal mice. Science 1986; 232:1423-5; PMID:3487115; http://dx.doi.org/10.1126/ science.3487115. (Pubitemid 16059397)
4. Hayakawa K, Hardy RR, Herzenberg LA et al. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J Exp Med 1985; 161:1554-68; PMID:3874257; http://dx.doi.org/10.1084/jem.161.6.1554.
5. Cunningham AJ. Large numbers of cells in normal mice produce antibody components of isologous erythrocytes. Nature 1974; 252:749-51; PMID:4140475; http://dx.doi.org/10.1038/252749a0.
6. Cunningham AJ, Steele EJ. Ontogeny of the autoimmune reaction in normal mice to antigens in erythrocytes and gut. Clin Exp Immunol 1981; 44:38-48; PMID:7021025. (Pubitemid 11139668)
7. Hayakawa K, Carmack CE, Hyman R et al. Natural autoantibodies to thymocytes: origin, VH genes, fine specificities, and the role of Thy-1 glycoprotein. J Exp Med 1990; 172:869-78; PMID:1974916; http:// dx.doi.org/10.1084/jem.172.3.869. (Pubitemid 20301233)
8. Gui M, Wiest DL, Li J et al. Peripheral CD4+ T cell maturation recognized by increased expression of Thy-1/CD90 bearing the 6C10 carbohydrate epitope. J Immunol 1999; 163:4796-804; PMID:10528179. (Pubitemid 29501242)
9. Hayakawa K, Hardy RR. Murine CD4+ T cell subsets defined. J Exp Med 1988; 168:1825-38; PMID:2903214; http://dx.doi.org/10.1084/jem.168.5.1825. (Pubitemid 19023265)
10. Nosten-Bertrand M, Errington ML, Murphy KP et al. Normal spatial learning despite regional inhibition of LTP in mice lacking Thy-1. Nature 1996; 379:826-9; PMID:8587606; http://dx.doi.org/10.1038/379826a0. (Pubitemid 26067724)
11. Hayakawa K, Asano M, Shinton SA et al. Positive selection of natural autoreactive B cells. Science 1999; 285:113-6; PMID:10390361; http://dx.doi.org/10.1126/science.285.5424.113. (Pubitemid 29307578)
12. Murakami M, Tsubata T, Okamoto M et al. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 1992; 357:77-80; PMID:1574128; http://dx.doi. org/10.1038/357077a0.
13. Okamoto M, Murakami M, Shimizu A et al. A transgenic model of autoimmune hemolytic anemia. J Exp Med 1992; 175:71-9; PMID:1730928; http://dx.doi.org/10. 1084/jem.175.1.71.
14. Hayakawa K, Asano M, Shinton SA et al. Positive selection of anti-thy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development. J Exp Med 2003; 197:87-99; PMID:12515816; http://dx.doi.org/10.1084/jem.20021459. (Pubitemid 36110260)
15. Goodnow CC, Crosbie J, Jorgensen H et al. Induction of self-tolerance in mature peripheral B lymphocytes. Nature 1989; 342:385-91; PMID:2586609; http://dx.doi.org/10.1038/342385a0. (Pubitemid 19277513)
16. Nemazee DA, Burki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 1989; 337:562-6; PMID:2783762; http://dx.doi.org/10.1038/337562a0. (Pubitemid 19045542)
17. Erikson J, Radic MZ, Camper SA et al. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 1991; 349:331-4; PMID:1898987; http://dx.doi.org/10.1038/349331a0. (Pubitemid 21912076)
18. Gay D, Saunders T, Camper S et al. Receptor editing: An approach by autoreactive B cells to escape tolerance. J Exp Med 1993; 177:999-1008; PMID:8459227; http://dx.doi.org/10.1084/jem.177.4.999. (Pubitemid 23097389)
19. Wen L, Brill-Dashoff J, Shinton SA et al. Evidence of marginal-zone B cell-positive selection in spleen. Immunity 2005; 23:297-308; PMID:16169502; http://dx.doi.org/10.1016/j.immuni.2005.08.007. (Pubitemid 41317797)
20. Tanigaki K, Han H, Yamamoto N et al. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat Immunol 2002; 3:443-50; PMID:11967543; http://dx.doi.org/10.1038/ni793.
21. Schiemann B, Gommerman JL, Vora K et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001; 293:2111-4; PMID:11509691; http://dx.doi. org/10.1126/science.1061964. (Pubitemid 32848063)
22. Schneider P, Takatsuka H, Wilson A et al. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J Exp Med 2001; 194:1691-7; PMID:11733583; http://dx.doi.org/10.1084/jem.194.11.1691.
23. Hardy RR, Hayakawa K. A developmental switch in B lymphopoiesis. Proc Natl Acad Sci USA 1991; 88:11550-4; PMID:1722338; http://dx.doi.org/10.1073/ pnas.88.24.11550.
24. Casola S, Otipoby KL, Alimzhanov M et al. B cell receptor signal strength determines B cell fate. Nat Immunol 2004; 5:317-27; PMID:14758357; http://dx.doi.org/10.1038/ni1036.
25. Baumgarth N, Herman OC, Jager GC et al. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 2000; 192:271-80; PMID:10899913; http://dx.doi.org/10.1084/jem.192.2.271. (Pubitemid 30470309)
26. Choi YS, Baumgarth N. Dual role for B-1a cells in immunity to influenza virus infection. J Exp Med 2008; 205:3053-64; PMID:19075288; http://dx.doi.org/10.1084/jem.20080979.
27. Pennell CA, Arnold LW, Haughton G et al. Restricted Ig variable region gene expression among Ly-1+ B cell lymphomas. J Immunol 1988; 141:2788-96; PMID:3139765. (Pubitemid 18263069)
28. Haughton G, Arnold LW, Bishop GA et al. The CH series of murine B cell lymphomas: Neoplastic analogues of Ly-1+ normal B cells. Immunol Rev 1986; 93:35-51; PMID:3491037; http://dx.doi. org/10.1111/j.1600-065X.1986.tb01501.x. (Pubitemid 17171498)